Development of a double-antibody sandwich ELISA for rapidly quantitative detection of residual non-structural proteins in inactivated foot-and-mouth disease virus vaccines

J Virol Methods. 2023 Apr:314:114676. doi: 10.1016/j.jviromet.2023.114676. Epub 2023 Jan 18.

Abstract

Foot-and-mouth disease (FMD) is a highly contagious and economically devastating disease of cloven-hoofed animals. Vaccination and surveillance against non-structure protein (NSP) are the most efficacious and cost-effective strategy to control this disease. Therefore, vaccine purity control is vital for successful prevention. Currently, vaccine purity is tested by an in-vivo test that recommended in the World Organization for Animal Health (WOAH), but it is time consuming and costly. Herein, we develop a double-antibody sandwich enzyme-linked immunosorbent assay (DAS-ELISA) for quantitative detection of residual NSPs in inactivated FMD virus (FMDV) vaccines. In this assay, the monoclonal antibody 3A24 was selected as capture antibody and biotinylated 3B4B1 (Biotin-3B4B1) as detection antibody. A standard curve was developed using the NSP 3AB concentration versus OD value with the linear range of concentration of 2.5-160 ng/mL. The lowest limit of detection was 2.5 ng/mL. In addition, we determined 2.5 ng/mL of NSP as an acceptable threshold value of FMD vaccine purity using a dose-response experiment in cattle. The DAS-ELISA combined with the threshold value of FMD vaccine purity could provide a quick and simple tool for evaluation the antigenic purity of FMD vaccine during the manufacturing process.

Keywords: DAS-ELISA; Foot-and-mouth disease; Non-structural proteins; Quantitative detection; Vaccine purity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral
  • Cattle
  • Enzyme-Linked Immunosorbent Assay / veterinary
  • Foot-and-Mouth Disease Virus*
  • Foot-and-Mouth Disease* / diagnosis
  • Foot-and-Mouth Disease* / prevention & control
  • Vaccines, Inactivated
  • Viral Vaccines*

Substances

  • Vaccines, Inactivated
  • Antibodies, Viral
  • Viral Vaccines